Works matching DE "CD34 antigen"


Results: 766
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Meningeal SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily B member 1 (SMARCB1)-deficient tumours: an emerging group of meningeal tumours.

    Published in:
    Neuropathology & Applied Neurobiology, 2017, v. 43, n. 5, p. 433, doi. 10.1111/nan.12364
    By:
    • Dadone, B.;
    • Fontaine, D.;
    • Mondot, L.;
    • Cristofari, G.;
    • Jouvet, A.;
    • Godfraind, C.;
    • Varlet, P.;
    • Ranchère‐Vince, D.;
    • Coindre, J.‐M.;
    • Gastaud, L.;
    • Baudoin, C.;
    • Peyron, A.‐C.;
    • Thyss, A.;
    • Coutts, M.;
    • Michiels, J.‐F.;
    • Pedeutour, F.;
    • Burel‐Vandenbos, F.
    Publication type:
    Article
    23
    24

    Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization.

    Published in:
    Bone Marrow Transplantation, 2015, v. 50, n. 1, p. 34, doi. 10.1038/bmt.2014.196
    By:
    • Sánchez-Ortega, I;
    • Querol, S;
    • Encuentra, M;
    • Ortega, S;
    • Serra, A;
    • Sanchez-Villegas, J M;
    • Grifols, J R;
    • Pujol-Balaguer, M M;
    • Pujol-Bosch, M;
    • Martí, J M;
    • Garcia-Cerecedo, T;
    • Barba, P;
    • Sancho, J M;
    • Esquirol, A;
    • Sierra, J;
    • Duarte, R F
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Solitary fibrous tumour of the scalp.

    Published in:
    Clinical & Experimental Dermatology, 2014, v. 39, n. 4, p. 539, doi. 10.1111/ced.12309
    By:
    • Omori, Y.;
    • Saeki, H.;
    • Ito, K.;
    • Matsuzaki, H.;
    • Tokita, M.;
    • Itoh, M.;
    • Tanito, K.;
    • Ishiji, T.;
    • Fukunaga, M.;
    • Nakagawa, H.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42

    A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.

    Published in:
    Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01548-3
    By:
    • Ishida, Hisashi;
    • Kawahara, Yuta;
    • Tomizawa, Daisuke;
    • Okamoto, Yasuhiro;
    • Hama, Asahito;
    • Cho, Yuko;
    • Koh, Katsuyoshi;
    • Koga, Yuhki;
    • Yoshida, Nao;
    • Sato, Maho;
    • Terui, Kiminori;
    • Miyagawa, Naoyuki;
    • Watanabe, Akihiro;
    • Takita, Junko;
    • Kobayashi, Ryoji;
    • Yamamoto, Masaki;
    • Watanabe, Kenichiro;
    • Okada, Keiko;
    • Kato, Koji;
    • Matsumoto, Kimikazu
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    Giant omental lipoblastoma and CD56 expression.

    Published in:
    African Journal of Paediatric Surgery, 2013, v. 10, n. 1, p. 32, doi. 10.4103/0189-6725.109389
    By:
    • Miyano, Go;
    • Hayashi, Takuo;
    • Arakawa, Atsushi;
    • Goto, Shumpei;
    • Lane, Geoffrey J.;
    • Okazaki, Tadaharu;
    • Yamataka, Atsuyuki
    Publication type:
    Article
    50